[EN] Background: Platinum doublets are standard chemotherapy for advanced non-small-cell lung cancer (NSCLC). The aim of this study was to assess whether neutropenia is: (1) an indicator for treatment efficacy, or (2) ...
Booth, Thomas C.; Wiegers, Evita C.; Warnert, Esther A. H.; Schmainda, Kathleen M.; Riemer, Frank; Nechifor, Ruben E.; Keil, Vera C.; Hangel, Gilbert; Figueiredo, Patrícia; Álvarez-Torres, María del Mar; Henriksen, Otto M.(Frontiers Media SA, 2022-02-28)
[EN] ObjectiveTo summarize evidence for use of advanced MRI techniques as monitoring biomarkers in the clinic, and to highlight the latest bench-to-bedside developments. MethodsThe current evidence regarding the potential ...
[EN] Background: In advanced-stage (IIIB or IV) non-small-cell lung cancer (NSCLC), combination chemotherapy has demonstrated response rates of 20% and a 1-year survival rate of 30%. We conducted a multicentre, open-label, ...